From April 1, 2022 to June 30, 2022, the company has repurchased 72,083 shares, representing 0.59% for KRW 6,595.56 million. With this, the company has completed the repurchase of 88,752 shares, representing 0.72% for KRW 8,184.14 million under the buyback announced on February 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
104,200 KRW | +2.76% | +2.26% | -20.40% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.40% | 945M | |
+22.69% | 43.81B | |
+25.56% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.